课题基金 / 基金详情

Male contraception/CatSper1,2 sperm-specific ion channe*

Male contraception/CatSper1,2 sperm-specific ion channe*
男性避孕/CatSper1,2精子特异性离子通道*
批准号:
6848353
负责人:
DAVID E. CLAPHAM
金额:
$15.18万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-01-30 至 2008-11-30

项目摘要

项目成果

DAVID E. CLAPHAM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The fusion of sperm and egg lead to the combination of the father's and mother's genetic information to create a new individual. In humans, as in all mammals, sperm must reach the egg, penetrate its protective coat, fuse with the oocyte membrane, and deliver its genetic material. Ion channels in the sperm mediate many of these steps, but most of these ion channels are also present in other tissues, including brain and heart. We have identified a class of ion channels, called CatSpers (Cation channel of Sperm) that are in mature sperm but not in any other tissues of the body, including developing organs. CatSpers are six transmembrane-spanning ion channel proteins localized primarily to the tail of mature sperm (Ren et al., 2001). CatSper1, the first of these ion channels to be identified, triggers calcium influx into the principal piece of the sperm tail. Calcium is required for sperm motility, and sperm from mice genetically engineered to lack the functional CatSper1 gene show a significant reduction in motility. Male mice homozygous for null-mutations in the CatSper1 gene are infertile (100%), but otherwise are completely normal. Another related sperm-specific protein, CatSper2, is also localized to its tail. Since these ion channels are only in mature sperm and required for fertility, a specific agent that blocks channel function should prevent fertilization. Experiments are proposed that will enable the expression of these novel genes in heterologous cell lines suitable for large-scale screening for small molecule blockers. This will provide a viable assay for screening for male contraceptive agents.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
  • 批准号:
    8394934
  • 项目类别:
  • 资助金额:
    $41.34万
  • 财政年份:
    2010
  • 负责人:
    DAVID E. CLAPHAM
  • 依托单位:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
  • 批准号:
    7864636
  • 项目类别:
  • 资助金额:
    $42.85万
  • 财政年份:
    2010
  • 负责人:
    DAVID E. CLAPHAM
  • 依托单位:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
  • 批准号:
    8590225
  • 项目类别:
  • 资助金额:
    $43.07万
  • 财政年份:
    2010
  • 负责人:
    DAVID E. CLAPHAM
  • 依托单位:
Canonical Transient Receptor Potential (TRPC) subfamily function in Hippocampus.
  • 批准号:
    8204512
  • 项目类别:
  • 资助金额:
    $43.07万
  • 财政年份:
    2010
  • 负责人:
    DAVID E. CLAPHAM
  • 依托单位:
国内基金
海外基金
Calcium/NFAT/GLUT3通路调控糖酵解代谢在CAR-T细胞耗竭中的作用和机制研究
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    52万元
  • 批准年份:
    2022
  • 负责人:
    张明明
  • 依托单位:
钙信号负向调节因子IRBIT抑制肝癌细胞恶性生物学行为的分子机制研究
  • 批准号:
    31960151
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    40.0万元
  • 批准年份:
    2019
  • 负责人:
    徐靖宇
  • 依托单位:
基于钙信号特征机制的肿瘤转移调控研究
  • 批准号:
    31970729
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    魏朝亮
  • 依托单位:
一种拟南芥IP3结合蛋白作用机制及功能研究
  • 批准号:
    31970723
  • 项目类别:
    面上项目
  • 资助金额:
    60.0万元
  • 批准年份:
    2019
  • 负责人:
    韩生成
  • 依托单位: